Planta Med 2003; 69(4): 289-299
DOI: 10.1055/s-2003-38871
Review
© Georg Thieme Verlag Stuttgart · New York

Artemisinin, a Novel Antimalarial Drug: Biochemical and Molecular Approaches for Enhanced Production

M. Z. Abdin1 , M. Israr1 , R. U. Rehman1 , S. K. Jain1
  • 1Centre for Biotechnology, Faculty of Science, Hamdard University, New Delhi, India
Weitere Informationen

Publikationsverlauf

Received: July 2, 2002

Accepted: November 16, 2002

Publikationsdatum:
23. April 2003 (online)

Preview

Abstract

Artemisinin, a sesquiterpene lactone containing an endoperoxide bridge, has been isolated from the aerial parts of Artemisia annua L. plants. It is effective against both drug-resistant and cerebral malaria-causing strains of Plasmodium falciparum. The relatively low yield (0.01 - 0.8 %) of artemisinin in A. annua is a serious limitation to the commercialization of the drug. Therefore, the enhanced production of artemisinin either in cell/tissue culture or in the whole plant of A. annua is highly desirable. It can be achieved by a better understanding of the biochemical pathway leading to the synthesis of artemisinin and its regulation by both exogenous and endogenous factors. Furthermore, genetic engineering tools can be employed to overexpress gene(s) coding for enzyme(s) associated with the rate limiting step(s) of artemisinin biosynthesis or to inhibit the enzyme(s) of other pathway competing for its precursors. These aspects which may be employed to enhance the yield of artemisinin both in vitro and in vivo are discussed in this review.

References

Dr. M. Z. Abdin

Centre for Biotechnology

Faculty of Science

Hamdard University,

New Delhi - 110 062

India

eMail: mzabdin@rediffmail.com

Fax: +91-11-60888874